Evidence map›Paper›PMID 26112289›Full record

ReviewBioinformatics (Oxford, England)2015

Data Safe Havens in health research and healthcare.

Paul R Burton, Madeleine J Murtagh, Andy Boyd, James B Williams, Edward S Dove, Susan E Wallace, Anne-Marie Tassé, Julian Little, Rex L Chisholm, Amadou Gaye and 6 more

Abstract readReview
In one paragraph

Review in Bioinformatics (Oxford, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A National Network of Safe Havens: Scottish Perspective.Journal of medical Internet research · 2022
    Article
  6. A deterministic approach for protecting privacy in sensitive personal data.BMC medical informatics and decision making · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Bringing Code to Data: Do Not Forget Governance.Journal of medical Internet research · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Paul R BurtonData to Knowledge (D2K) Research Group, University of Bristol, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, UK, Public Population Project in Genomics and Society (PG), Montreal, QC H3A 0G1, Canada.
Madeleine J MurtaghData to Knowledge (D2K) Research Group, University of Bristol, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, UK.
Andy BoydData to Knowledge (D2K) Research Group, University of Bristol, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, UK.
James B WilliamsDepartment of Computer Science, University of Toronto, Sandford Fleming Building, Toronto, ON M5S 3G4, Canada.
Edward S DoveJK Mason Institute for Medicine, Life Sciences and the Law, School of Law, University of Edinburgh, Old College, South Bridge, Edinburgh EH8 9YL, UK.
Susan E WallacePublic Population Project in Genomics and Society (PG), Montreal, QC H3A 0G1, Canada, Department of Health Sciences, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, UK.
Anne-Marie TasséPublic Population Project in Genomics and Society (PG), Montreal, QC H3A 0G1, Canada.
Julian LittleSchool of Epidemiology, Public Health and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Rex L ChisholmCenter for Genetic Medicine and Surgery, Northwestern University, Rubloff Building, 750 N Lake Shore, Chicago, IL 60611, USA.
Amadou GayeData to Knowledge (D2K) Research Group, University of Bristol, Oakfield House, Oakfield Grove, Clifton, Bristol BS8 2BN, UK.
Kristian HveemDepartment of Public Health and General Practice, Norwegian University of Science and Technology, Postboks 8905, 7401 Trondheim, Norway.
Anthony J BrookesDepartment of Health Sciences, University of Leicester, Adrian Building, University Road, Leicester LE1 7RH, UK.
Pat GoodwinC3 Collaborating for Health, 7-14 Great Dover Street, London SE1 4YR.
Jon FisteinMRC Medical Bioinformatics Centre, Leeds Institute of Health Sciences, University of Leeds, University of Leeds, Charles Thackrah Building,101 Clarendon Road, Leeds LS2 9LJ.
Martin BobrowUniversity of Cambridge, Wolfson College, Cambridge CB3 9BB, UK and.
Bartha M KnoppersPublic Population Project in Genomics and Society (PG), Montreal, QC H3A 0G1, Canada, Centre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
CIHRMedical Research Council G1001799Medical Research Council G1001799/2Medical Research Council MC_PC_15018Medical Research Council MR/K006525/1Medical Research Council MR/K007017/1Medical Research Council MR/L01629X/1Medical Research Council MR/N01104X/1NCI NIH HHS P30 CA060553Wellcome Trust 102215Wellcome Trust 102215/Z/13/ZWellcome Trust 103360Wellcome Trust WT086118/Z/08/Z
6 · The paper itself

Abstract

motivationThe data that put the 'evidence' into 'evidence-based medicine' are central to developments in public health, primary and hospital care. A fundamental challenge is to site such data in repositories that can easily be accessed under appropriate technical and governance controls which are effectively audited and are viewed as trustworthy by diverse stakeholders. This demands socio-technical solutions that may easily become enmeshed in protracted debate and controversy as they encounter the norms, values, expectations and concerns of diverse stakeholders. In this context, the development of what are called 'Data Safe Havens' has been crucial. Unfortunately, the origins and evolution of the term have led to a range of different definitions being assumed by different groups. There is, however, an intuitively meaningful interpretation that is often assumed by those who have not previously encountered the term: a repository in which useful but potentially sensitive data may be kept securely under governance and informatics systems that are fit-for-purpose and appropriately tailored to the nature of the data being maintained, and may be accessed and utilized by legitimate users undertaking work and research contributing to biomedicine, health and/or to ongoing development of healthcare systems.

resultsThis review explores a fundamental question: 'what are the specific criteria that ought reasonably to be met by a data repository if it is to be seen as consistent with this interpretation and viewed as worthy of being accorded the status of 'Data Safe Haven' by key stakeholders'? We propose 12 such criteria. CONTACT: paul.burton@bristol.ac.uk.

Indexed as

Access to InformationBiomedical ResearchConfidentialityDelivery of Health CareHumansResearch

Identifiers

PMID26112289
PMCPMC4595892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.